Patient preferences regarding incidental genomic findings discovered during tumor profiling

Cancer

Volumn 122, Issue 10, 2016, Pages 1588-1597

  Yushak, Melinda L ^a   Han, Gang ^b   Bouberhan, Sara ^b   Epstein, Lianne ^b   Digiovanna, Michael P ^b   Mougalian, Sarah S ^b   Sanft, Tara B ^b   Abu Khalaf, Maysa M ^b   Chung, Gina G ^b   Stein, Stacey M ^b   Goldberg, Sarah B ^b   Pusztai, Lajos ^b   Hofstatter, Erin W ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

disclosure; genome; genomics; germline mutation; incidental findings; questionnaire

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER PATIENT; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DESCRIPTIVE RESEARCH; DIGESTIVE SYSTEM CANCER; FEMALE; GENETIC PREDISPOSITION; GENETIC PRIVACY; GENETIC VARIABILITY; GENOME ANALYSIS; HEALTH INSURANCE; HUMAN; INCIDENTAL FINDING; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; METASTASIS; PATIENT PREFERENCE; PRIORITY JOURNAL; QUESTIONNAIRE; COHORT ANALYSIS; GENETICS; GERMLINE MUTATION; INTERPERSONAL COMMUNICATION; MIDDLE AGED; NEOPLASM; PATHOLOGY; PSYCHOLOGY; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DISCLOSURE; GERM-LINE MUTATION; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PATIENT PREFERENCE; SURVEYS AND QUESTIONNAIRES;

EID: 84960421177     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.29951     Document Type: Article

References (25)

1. Robson ME, Bradbury AR, Arun B, et al., American Society of Clinical Oncology Policy Statement Update: genetic and genomic testing for cancer susceptibility. J Clin Oncol. 2015; 33: 3660-3667.
2. Raymond VM, Gray SW, Roychowdhury S, et al,; Clinical Sequencing Exploratory Research Consortium Tumor Working Group. Germline findings in tumor-only sequencing: points to consider for clinicians and laboratories. J Natl Cancer Inst. 2015; 108 (4). pii: djv351. doi: 10.1093/jnci/djv351.
3. Schrader KA, Cheng DT, Vijai J, et al., Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA. JAMA Oncol. 2016; 2 (1): 104-111.
4. Meric-Bernstam F, Brusco L, Daniels MS, et al., Incidental germline variants in 1000 advanced cancers on a prospective somatic genomic profiling protocol. Ann Oncol. 2016. pii: mdw018. [Epub ahead of print].
5. Stratton MR, Campbell PJ, Futreal PA,. The cancer genome. Nature. 2009; 458: 719-724.
6. McGuire AL, Joffe S, Koenig BA, et al., Point-counterpoint. Ethics and genomic incidental findings. Science. 2013; 340: 1047-1048.
7. Kwon JM, Steiner RD,. " I'm fine; I'm just waiting for my disease": the new and growing class of presymptomatic patients. Neurology. 2011; 77: 522-523.
8. Holtzman NA,. ACMG recommendations on incidental findings are flawed scientifically and ethically. Genet Med. 2013; 15: 750-751.
9. Green RC, Berg JS, Grody WW, et al,; American College of Medical Genetics and Genomics. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet Med. 2013; 15: 565-574.
10. Smith LA, Douglas J, Braxton AA, Kramer K,. Reporting incidental findings in clinical whole exome sequencing: incorporation of the 2013 ACMG recommendations into current practices of genetic counseling. J Genet Couns. 2015; 24: 654-662.
11. Yu JH, Harrell TM, Jamal SM, Tabor HK, Bamshad MJ,. Attitudes of genetics professionals toward the return of incidental results from exome and whole-genome sequencing. Am J Hum Genet. 2014; 95: 77-84.
12. American College of Medical Genetics and Genomics. ACMG updates recommendation on "opt out" for genome sequencing return of results [press release]. Bethesda, MD: American College of Medical Genetics and Genomics; April 1, 2014. https://www.acmg.net/docs/gim2014151a.pdf. Accessed February 22, 2016.
13. Wolf SM, Annas GJ, Elias S,. Point-counterpoint. Patient autonomy and incidental findings in clinical genomics. Science. 2013; 340: 1049-1050.
14. Parsons DW, Roy A, Plon SE, Roychowdhury S, Chinnaiyan AM,. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings. J Clin Oncol. 2014; 32: 2203-2205.
15. Rosenblatt DS,. Who's on first in exome and whole genome sequencing? Is it the patient or the incidental findings? Mol Genet Metab. 2013; 110: 1-2.
16. Townsend A, Adam S, Birch PH, Friedman JM,. Paternalism and the ACMG recommendations on genomic incidental findings: patients seen but not heard. Genet Med. 2013; 15: 751-752.
17. Fleming J, Critchley C, Otlowski M, Stewart C, Kerridge I,. Attitudes of the general public towards the disclosure of individual research results and incidental findings from biobank genomic research in Australia. Intern Med J. 2015; 45: 1274-1279.
18. Regier DA, Peacock SJ, Pataky R, et al., Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment. CMAJ. 2015; 187: E190-E197.
19. Miller FA, Hayeems RZ, Bytautas JP, et al., Testing personalized medicine: patient and physician expectations of next-generation genomic sequencing in late-stage cancer care. Eur J Hum Genet. 2014; 22: 391-395.
20. Gray SW, Wagle N, Garber JE, et al., Oncologists' and cancer patients' views on whole-exome sequencing and incidental findings: results from the CanSeq study. Genet Med. 2016 [Epub ahead of print]. doi: 10.1038/gim.2015.207.
21. Master Z, Claudio JO, Rachul C, Wang JC, Minden MD Caulfield T,. Cancer patient perceptions on the ethical and legal issues related to biobanking. BMC Med Genomics. 2013; 6: 8.
22. Bullock AJ, Hofstatter EW, Yushak ML, Buss MK,. Understanding patients' attitudes toward communication about the cost of cancer care. J Oncol Pract. 2012; 8: e50-e58.
23. Bennette CS, Trinidad SB, Fullerton SM, et al., Return of incidental findings in genomic medicine: measuring what patients value-development of an instrument to measure preferences for information from next-generation testing (IMPRINT). Genet Med. 2013; 15: 873-881.
24. Clift KE, Halverson C, Fiksdal AS, Kumbamu A, Sharp R, McCormick J,. Patients' views on incidental findings from clinical exome sequencing. Appl Transl Genomics. 2015; 4: 38-43.
25. Yusuf RA, Rogith D, Hovick S, et al., Attitudes toward molecular testing for personalized cancer therapy. Cancer. 2015; 121: 243-250.